Federal contract award
75N93020C00004
ERMES EVALUATION OF RADIOMITIGATIVE EFFICACY AND SAFETY OF BP-C2
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $6.3M |
| Current contract value | $6.3M |
| Potential contract value / ceiling | $6.3M |
| Start date | May 1, 2020 |
| Current end date | Apr 30, 2025 |
| Potential end date | Apr 30, 2025 |
| Latest award activity | Sep 4, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 22 of 22 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 4, 2026 | P00021 | $-96.7K | TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS. |
| Jan 16, 2025 | P00020 | $-2 | ERMES EVALUATION OF RADIOMITIGATIVE EFFICACY AND SAFETY OF BP-C2 |
| Aug 28, 2024 | P00019 | $0 | ERMES EVALUATION OF RADIOMITIGATIVE EFFICACY AND SAFETY OF BP-C2 |
| Feb 26, 2024 | P00018 | $0 | ERMES EVALUATION OF RADIOMITIGATIVE EFFICACY AND SAFETY OF BP-C2 |
| Sep 5, 2023 | P00017 | $0 | ERMES EVALUATION OF RADIOMITIGATIVE EFFICACY AND SAFETY OF BP-C2 |
| Apr 27, 2023 | P00016 | $0 | ERMES EVALUATION OF RADIOMITIGATIVE EFFICACY AND SAFETY OF BP-C2 |
| Feb 28, 2023 | P00015 | $0 | ERMES EVALUATION OF RADIOMITIGATIVE EFFICACY AND SAFETY OF BP-C2 |
| Feb 2, 2023 | P00014 | $0 | IPP: ERMES EVALUATION OF RADIOMITIGATIVE EFFICACY AND SAFETY OF BP-C2 |
| Nov 15, 2022 | P00013 | $0 | IPP: ERMES EVALUATION OF RADIOMITIGATIVE EFFICACY AND SAFETY OF BP-C2 |
| Aug 26, 2022 | P00012 | $39.0K | ERMES EVALUATION OF RADIOMITIGATIVE EFFICACY AND SAFETY OF BP-C2 |
| Jul 19, 2022 | P00011 | $27.2K | ERMES EVALUATION OF RADIOMITIGATIVE EFFICACY AND SAFETY OF BP-C2 |
| Jul 13, 2022 | P00010 | $0 | ERMES EVALUATION OF RADIOMITIGATIVE EFFICACY AND SAFETY OF BP-C2 |
| Apr 28, 2022 | P00009 | $2.0M | ERMES EVALUATION OF RADIOMITIGATIVE EFFICACY AND SAFETY OF BP-C2 |
| Dec 1, 2021 | P00008 | $0 | ERMES EVALUATION OF RADIOMITIGATIVE EFFICACY AND SAFETY OF BP-C2 |
| Sep 15, 2021 | P00007 | $405.6K | ERMES EVALUATION OF RADIOMITIGATIVE EFFICACY AND SAFETY OF BP-C2 |
| Jul 13, 2021 | P00006 | $100.0K | ERMES EVALUATION OF RADIOMITIGATIVE EFFICACY AND SAFETY OF BP-C2 |
| Apr 29, 2021 | P00005 | $1.9M | ERMES EVALUATION OF RADIOMITIGATIVE EFFICACY AND SAFETY OF BP-C2 |
| Apr 21, 2021 | P00004 | $0 | ERMES EVALUATION OF RADIOMITIGATIVE EFFICACY AND SAFETY OF BP-C2 |
| Feb 12, 2021 | P00003 | $0 | ERMES EVALUATION OF RADIOMITIGATIVE EFFICACY AND SAFETY OF BP-C2 EDITED BY PATELAP2_NIH ON 02/12/2021 16:24:29 EDITED BY PATELAP2_NIH ON 02/12/2021 16:24:40 |
| Dec 14, 2020 | P00002 | $0 | ERMES EVALUATION OF RADIOMITIGATIVE EFFICACY AND SAFETY OF BP-C2 |
| Jul 20, 2020 | P00001 | $0 | ERMES EVALUATION OF RADIOMITIGATIVE EFFICACY AND SAFETY OF BP-C2 |
| Apr 30, 2020 | 0 | $2.0M | ERMES EVALUATION OF RADIOMITIGATIVE EFFICACY AND SAFETY OF BP-C2 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.